INSIGHTS ON DRUG DEVELOPMENT
-
![Weight Loss_GettyImages-2123088969]( "Advancements In GLP-1 Analog Formulation: Overcoming Challenges")
Advancements In GLP-1 Analog Formulation: Overcoming ChallengesOral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
![GettyImages-1388387927-computer-scans-brain-doctor-pen]( "Assessing Viability And Real-Time Apoptosis/Necrosis")
Assessing Viability And Real-Time Apoptosis/NecrosisMalignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.
-
![GettyImages-2150054374-RNA-strand-3d-molecules]( "Accelerating mRNA Therapy Production With Digital Innovation")
Accelerating mRNA Therapy Production With Digital InnovationScaling mRNA therapies requires more than innovation—it demands precision. Discover how digital tools like automation and analytics are helping life science companies streamline production.
-
![Cytiva Minimate]( "Benchmarking Filtration Performance Of TFF Cassettes")
Benchmarking Filtration Performance Of TFF CassettesOptimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
-
Step-By-Step Guide To Tech Transfer Preparation And Execution10/31/2024
How does a sponsor accurately transfer detailed knowledge about its product composition, development, and current manufacturing processes to its CDMO?
-
How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions8/11/2025
With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence
-
Development Of A Non-Standard Protein Therapeutic2/4/2026
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids3/10/2025
Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.
-
Bioanalytical Quantification Of A Biotherapeutic Peptide7/17/2025
Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.
DRUG DEVELOPMENT SOLUTIONS
-
![Scientist in lab GettyImages-872025342]( "Drug-Drug Interaction (DDI) Studies")
Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
-
![GettyImages-1127105013-lab-computer-research-scientist]( "Solid Form Services")
We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.
-
![Affinity-ITC]( "Microcalorimeters For In-Depth Characterization")
Powerful tools for characterizing protein-protein interactions, structural stability, and formulation compatibility.
-
![ExionLC™ 2.0 and ExionLC™]( "ExionLC™ 2.0 and ExionLC™ 2.0+ Systems")
Reproducibility, reliability and carryover performance that meets your workflow demands, injection to injection, batch after batch.
ExionLC 2.0 and ExionLC 2.0+ systems provide full integration, control and compatibility with SCIEX mass spectrometers bringing together the speed and precision you expect for a complete solution that meets every challenge your lab faces.
-
![drug-delivery-GettyImages-2214027401]( "Drug Delivery Materials")
Learn how tailored lipids, polymers, and carbohydrate‑based materials strengthen targeted delivery, enhance stability, and support scalable development for emerging therapeutic modalities.
